Skip to main content
Victor Chow, MD, Oncology, Seattle, WA

VictorAlexanderChowMD

Oncology • Seattle, WA

Hematologic Oncology

Sr. Clinical Trial Physician

Join to view full profile

Dr. Chow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chow's full profile

Already have an account?

  • Office

    Bristol Myers Squibb
    Seattle, WA 98109

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 2016 - 2019
  • University of Washington
    University of WashingtonResidency, Internal Medicine, 2013 - 2016
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 2013, MD

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2015 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Translating Anti-CD19 CAR T-cell Therapy into Clinical Practice for relapsed/refractory Diffuse Large B-cell Lymphoma  
    Mazyar Shadman, Ajay K Gopal, Victor A Chow, Blood

Abstracts/Posters

  • Low Achievement of End of Life Quality Measures in Large B-Cell Lymphoma Patients Who Progressed after CD19-Specific CAR-T Cell Therapy
    Victor A. Chow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Impact of Lab Abnormalities at the Time of Progression in Patients Receiving CD19-Specific CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas
    Victor A. Chow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials
    Victor A. Chow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell TherapyClinically Relevant Abstract 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Fred Hutch at ASH: Press Briefing on CAR T-cell Therapy, CRISPR for Blood Disorders, More
    Fred Hutch at ASH: Press Briefing on CAR T-cell Therapy, CRISPR for Blood Disorders, MoreNovember 26th, 2018

Dr. Victor Chow, Dr. Victor Chow, MD, Dr. V Chow, Dr. Victor Alexander Chow